FURIEX PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
FURIEX PHARMACEUTICALS, INC. reported Earnings Per Share, Basic and Diluted of -$2.92 per share for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-17.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2014-03-17
- FURIEX PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2013-12-31 was -$0.63.
- FURIEX PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2013-09-30 was -$0.85.
- FURIEX PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2013-06-30 was -$2.32.
- FURIEX PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2012-12-31 was -$0.90.
- FURIEX PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2013 was -$2.92.
- FURIEX PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2012 was -$4.29.
- FURIEX PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2011 was -$4.96.
- FURIEX PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2010 was -$5.53.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2013-12-31 | -$0.63 derived: net income ÷ weighted average shares · filed 2014-03-17 | -$1.49 derived: net income ÷ weighted average shares · filed 2014-03-17 | -$3.79 derived: net income ÷ weighted average shares · filed 2014-03-17 | -$2.92 10-K · filed 2014-03-17 |
| 2013-09-30 | -$0.85 10-Q · filed 2013-11-12 | -$3.17 derived: net income ÷ weighted average shares · filed 2014-03-17 | -$2.29 10-Q · filed 2013-11-12 | |
| 2013-06-30 | -$2.32 10-Q · filed 2013-08-08 | -$1.44 10-Q · filed 2013-08-08 | ||
| 2012-12-31 | -$0.90 10-K · filed 2014-03-17 | -$1.23 derived: net income ÷ weighted average shares · filed 2014-03-17 | -$3.31 derived: net income ÷ weighted average shares · filed 2014-03-17 | -$4.29 10-K · filed 2014-03-17 |
| 2012-09-30 | -$0.33 10-K · filed 2014-03-17 | -$2.41 derived: net income ÷ weighted average shares · filed 2014-03-17 | -$3.39 10-Q · filed 2013-11-12 | |
| 2012-06-30 | -$2.09 10-K · filed 2014-03-17 | -$3.07 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | -$0.98 10-K · filed 2014-03-17 | |||
| 2011-12-31 | -$0.68 10-K · filed 2013-03-18 | -$2.00 derived: net income ÷ weighted average shares · filed 2014-03-17 | -$3.50 derived: net income ÷ weighted average shares · filed 2014-03-17 | -$4.96 10-K · filed 2014-03-17 |
| 2011-09-30 | -$1.32 10-K · filed 2013-03-18 | -$2.82 derived: net income ÷ weighted average shares · filed 2013-03-18 | -$4.28 10-Q · filed 2012-11-06 | |
| 2011-06-30 | -$1.51 10-K · filed 2013-03-18 | -$2.96 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | -$1.45 10-K · filed 2013-03-18 | |||
| 2010-12-31 | -$5.53 10-K · filed 2013-03-18 | |||
| 2010-09-30 | -$2.14 10-Q · filed 2011-11-10 | -$4.35 10-Q · filed 2011-11-10 | ||
| 2010-06-30 | -$1.13 10-Q · filed 2011-08-10 | -$2.21 10-Q · filed 2011-08-10 | ||
| 2009-12-31 | -$0.90 10-K · filed 2012-03-07 |